HengRui USA is a wholly owned subsidiary of our parent company Jiangsu Hengrui Medicine. The foundation of HengRui USA is rooted in our parent company Jiangsu Hengrui Medicine’s rich heritage of over 200 pipelines and products across therapeutic areas such as oncology, metabolics, autoimmune, pain management, etc.
Our work here at HengRui USA focuses on the multiple stages of the drug development process, from a clinical, regulatory, and pre-commercialization perspective. HengRui USA operates as the U.S. hub for our parent company from our home office location in Princeton, NJ. Strategic capabilities are being built to transition from a clinical-stage to commercial-stage biotechnology company. |
About |
R&d |
|